ANNOUNCEMENT

Check out the MedCity CONVERGE speaker lineup: Pfizer, Cleveland Clinic, Intel and more.

Topic: Sarepta Therapeutics

New-look Sarepta eyes approval for muscular dystrophy drug

New-look Sarepta eyes approval for muscular dystrophy drug

April 2, 2013 1:51 pm by | 0 Comments

(Reuters) - After three decades without bringing a drug to market, Sarepta Therapeutics Inc stands on the verge of a breakthrough with its treatment for a crippling genetic disorder that ... Read more
Sarepta’s muscle disorder drug improves walking ability in trial

Sarepta’s muscle disorder drug improves walking ability in trial

October 3, 2012 7:14 am by | 0 Comments

(Reuters) - Sarepta Therapeutics Inc said its experimental drug met the main goal of improving walking ability in patients with a rare muscle disorder in a mid-stage trial.The drug eteplirsen ... Read more
Sarepta’s drugs to treat Ebola and Marburg virus get fast track status from FDA

Sarepta’s drugs to treat Ebola and Marburg virus get fast track status from FDA

September 18, 2012 10:19 am by | 0 Comments

(Reuters) - Biotechnology company Sarepta Therapeutics Inc said U.S. health regulators granted fast track status to two of its experimental drugs for the treatment of the Marburg and Ebola viruses.Shares ... Read more
Sarepta Therapeutics gets stop-work order about Ebola from US Department of Defense

Sarepta Therapeutics gets stop-work order about Ebola from US Department of Defense

August 4, 2012 7:10 pm by | 0 Comments

Sarepta Therapeutics (NASDAQ: SRPT) received a stop-work order from the U.S. Department of Defense with respect to the Ebola portion of the contract for Advanced Development of Hemorrhagic Fever Virus ... Read more